Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 33342-195

10 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 33342-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

666 (Venlafaxine Structure)

666 (Venlafaxine Structure)
Chemical structure of venlafaxine hydrochloride showing the molecular arrangement including a methoxyphenyl group, a cyclohexanol ring, and a dimethylaminoethyl side chain, labeled with the compound name and hydrochloride salt.*
FDA Label Image

234 (Venlafaxine Figure 1)

234 (Venlafaxine Figure 1)
A dot plot chart illustrating fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine and ODV across various special populations and conditions, including hepatic and renal impairment, CYP2D6 polymorphism, age, and gender. The x-axis represents change relative to a reference value, with values ranging from 0 to 3.5 fold change.*
FDA Label Image

456 (Venlafaxine Figure 2)

456 (Venlafaxine Figure 2)
A scatter plot showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax, AUC, and clearance (Cl/F) of venlafaxine and its metabolite ODV in presence of various interacting drugs. The x-axis represents fold change relative to a reference value, while the y-axis lists interacting drugs including Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium.*
FDA Label Image

567 (Venlafaxine Figure 3)

567 (Venlafaxine Figure 3)
A forest plot chart depicting fold change and 90% confidence intervals for various analytes including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis shows the change relative to a reference value for pharmacokinetic parameters such as Cmax and AUC.*
FDA Label Image

123 (Venlafaxine 37 5mg 30s Cont)

123 (Venlafaxine 37 5mg 30s Cont)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 37.5 mg strength, oral capsule dosage form. The label indicates a bottle of 30 capsules. It is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., with storage instructions and usage notes included.*
FDA Label Image

234 (Venlafaxine 37 5mg 500s Cont)

234 (Venlafaxine 37 5mg 500s Cont)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg, manufactured by Macleods Pharmaceuticals Limited. The label indicates 500 capsules per container and provides storage instructions and dosage guidance to see package insert. The product is labeled for oral use and includes barcodes and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

765 (Venlafaxine 75mg 30s Cont)

765 (Venlafaxine 75mg 30s Cont)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg strength, oral dosage form. The label states the product is manufactured by Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. It includes storage instructions and a directive to pharmacists to dispense the Medication Guide. The package contains 30 capsules.*
FDA Label Image

543 (Venlafaxine 75mg 500s Cont)

543 (Venlafaxine 75mg 500s Cont)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg by Macleods Pharmaceuticals Limited. This oral prescription medication is packaged in bottles of 500 capsules. The label includes dosage strength, manufacturer details, storage instructions, and NDC 33342-195-15.*
FDA Label Image

432 (Venlafaxine 150mg 30s Cont)

432 (Venlafaxine 150mg 30s Cont)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Macleods Pharmaceuticals Limited. Capsule count is 30. Label mentions extended release form containing venlafaxine hydrochloride USP equivalent to 150 mg venlafaxine. Storage instructions specify 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F). Manufacturer information includes Macleods Pharma USA, Inc. in Princeton, NJ, and Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, India.*
FDA Label Image

456 (Venlafaxine 150mg 500s Cont)

456 (Venlafaxine 150mg 500s Cont)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Macleods Pharma USA. The label indicates a container of 500 capsules. It includes storage instructions and manufacturing details for Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India, and Macleods Pharma USA, Inc., Princeton, NJ. The label also contains barcode and pharmacist dispensing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.